This article is more than 5 years old. Information may no longer be current.

VIDEO: Oral eplerenone successfully treats central serous chorioretinopathy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEPTUNE, N.J. – A 58-year-old man with distorted vision was diagnosed with central serous chorioretinopathy and was successfully treated with oral eplerenone, 25 mg twice a day, according to Yuyeng Lor, OD, MPH, here at a New Jersey Academy of Optometry continuing education event.

This mineralocorticoid receptor agonist acts as a diuretic, Lor said, and at the patient’s 6-month follow-up the subretinal fluid had resolved, and his vision returned to 20/20.

The NJAO provided a grant for Lor to present her research at the American Academy of Optometry meeting.

Disclosure: Lor reports no relevant financial disclosures.